Centrality, Mobility, and Specialization: A Study of Drug Markets in a Non-metropolitan Area in the United Kingdom

DOI10.1177/0022042619891962
Published date01 April 2020
AuthorLaura Baika,Paolo Campana
Date01 April 2020
Subject MatterArticles
https://doi.org/10.1177/0022042619891962
Journal of Drug Issues
2020, Vol. 50(2) 107 –126
© The Author(s) 2019
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/0022042619891962
journals.sagepub.com/home/jod
Article
Centrality, Mobility, and
Specialization: A Study of Drug
Markets in a Non-metropolitan
Area in the United Kingdom
Laura Baika1 and Paolo Campana1
Abstract
This article empirically explores the structure and mechanisms underpinning the local drug
markets in a non-metropolitan area in the United Kingdom. It relies on 3 years’ worth of
police records supplemented with qualitative evidence. It shows that, overall, supplying drugs
is a rather fragmented business; yet, there are indications of structural differentiation both in
terms of positions and roles. Furthermore, substantial differences emerge across drug types—
with heroin and cocaine networks showing a higher tendency toward cooperation and group
formation (higher average degree and lower fragmentation). This might be due to a higher need
for protection and more complex supply chains. Drug suppliers tend to specialize in relation
to the Class A drugs, their role in the market, and the territory in which they operate. Finally,
members of organized crime groups possess significantly higher degree centrality than non-
members, suggesting an ability to exert influence on the market.
Keywords
drug supply, centrality, mobility, specialization, organized crime, network analysis
Introduction
The illegal drug trade is a lucrative, well-established market that features prominently on the
global policy agenda (Bonfield, 2011). There is substantial agreement on the negative political,
cultural, and economic effects of the illegal drug trade (Her Majesty’s Government, 2017;
McSweeney et al., 2008). The trade and use of drugs can cause serious harm to communities
through drug-related violence, antisocial behavior, acquisitive crime, and knife and firearms
offenses. For instance, in the United Kingdom, there were 2,000 drug-related deaths recorded by
the British authorities in 2012 (Her Majesty’s Government, 2013). The social and economic costs
of the illegal drug trade are assessed to be £10.7 billion per year, of which just over half (£6 bil-
lion) is ascribed to drug-related acquisitive crime (Her Majesty’s Government, 2017). The U.K.
drug market itself is estimated to be worth around £3.7 billion per year (Her Majesty’s
Government, 2013). In addition, it is reported that around half of all organized crime groups
(OCGs) in the United Kingdom are involved in the drug trade (Her Majesty’s Government,
1University of Cambridge, UK
Corresponding Author:
Paolo Campana, Institute of Criminology, University of Cambridge, Sidgwick Avenue, Cambridge CB3 9DA, UK.
Email: pc524@cam.ac.uk
891962JODXXX10.1177/0022042619891962Journal of Drug IssuesBaika and Campana
research-article2019
108 Journal of Drug Issues 50(2)
2017). However, despite its relevance to large areas of public policy, there is still a paucity of
research into the structure and mechanisms underpinning drug markets and the operations of
drug distribution networks. This is particularly true in the case of the United Kingdom, where the
majority of empirical research on the street-level drug trade is qualitative in nature, typically
employing interviews with convicted drug offenders. However, individual traders often have a
very limited view of the workings of the entire market. In addition, studies analyzing these net-
works have often amalgamated data on different drugs without considering the variances across
markets. Furthermore, past research has typically looked at metropolitan settings, thus overlook-
ing the workings of markets outside large metropolitan areas.
The aim of this article is to expand on the existing literature by empirically investigating the
structure of a local street-level drug market in a midsize non-metropolitan urban area using a
social network analysis approach. This study is supply based, focusing exclusively on the supply
side of the drug trade, as opposed to demand-based studies that focus on how drug users get their
drugs (Potter, 2009). It aims to reconstruct the (offline) drug markets in Newport, Wales (UK),
through the study of crime events as recorded by the Gwent Police Service. The evidence for this
article includes quantitative data on co-participation in crime events as well as intelligence
records on active OCGs. We supplemented this evidence with qualitative interviews with police
officers working with the Gwent Police Service.
The Organization of Drug Markets
An illegal drug market can be defined as a black market devoted to the cultivation, manufacture,
distribution, and sale of drugs that are subject to drug prohibition laws (in line with Unodc.org,
2018). The definition of illegal drugs varies across countries due to different drug prohibition
laws. In the United Kingdom, for instance, the majority of illegal drugs are controlled under the
Misuse of Drugs Act 1971 and categorized into three separate groups of Classes A, B, and C, with
Class A inducing the most serious punishments and fines (Table 1).1
The drug seizure figures indicate that cannabis is the most seized drug in England and Wales,
followed by cocaine. Benzodiazepine is the most seized Class C drug across England and Wales
(Broadfield & Marshall, 2017; DrugWise, 2018).
How are these drugs supplied? In recent years, a growing body of research has investigated
and explored the diverse structures of (offline) drug distribution systems, and how such systems
operate at local, regional, national, and international levels (Dorn et al., 2005). Past research has
commonly found that drug trade networks differ in their size and complexity, ranging from
Table 1. The Most Common Illegal Drugs in the United Kingdom by Class.
Class A Class B Class C
Cocaine
Crack cocaine
Ecstasy (MDMA)
Heroin
LSD
Magic mushrooms
Methadone
Methamphetamine (crystal meth)
Amphetamines
Barbiturates
Cannabis
Codeine
Ketamine
Methylphenidate (Ritalin)
Synthetic cannabinoids
Synthetic cathinones (e.g.,
mephedrone, methoxetamine)
Anabolic steroids
Benzodiazepines (diazepam)
Gamma hydroxybutyrate (GHB)
Gamma-butyrolactone (GBL)
Khat
Piperazines (BZP)
Source. Gov.uk. (2018).
Note. LSD = lysergic acid diethylamide.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT